Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.10
+1.19 (3.85%)
At close: Jun 3, 2026, 4:00 PM EDT
31.94
-0.16 (-0.50%)
After-hours: Jun 3, 2026, 7:07 PM EDT
HRMY Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $44.36. The average 1-year stock price forecast is 38.19% higher than the current stock price, while the lowest is $28 (-12.77%) and the highest is $85 (+164.80%).
Price Target: $44.36 (+38.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +71.34% | May 22, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $50 | Buy | Reiterates | $50 | +55.76% | May 11, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $25 → $29 | Hold | Maintains | $25 → $29 | -9.66% | May 8, 2026 |
| Needham | Needham | Buy Reiterates $45 | Buy | Reiterates | $45 | +40.19% | May 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $62 → $72 | Buy | Maintains | $62 → $72 | +124.30% | Apr 22, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 868.45M
Increased by 18.60%
Revenue Next Year
1.16B
from 1.03B
Increased by 12.72%
EPS This Year
3.67
from 2.71
Increased by 35.46%
EPS Next Year
4.27
from 3.67
Increased by 16.45%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.1B | 1.3B | ||||||
| Avg | 1.0B | 1.2B | ||||||
| Low | 958.5M | 918.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 23.9% | 28.9% | ||||||
| Avg | 18.6% | 12.7% | ||||||
| Low | 10.4% | -10.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.62 | 5.55 | |||
| Avg | 3.67 | 4.27 | |||
| Low | 2.56 | 2.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 107.3% | 51.3% | |||
| Avg | 35.5% | 16.4% | |||
| Low | -5.6% | -19.6% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.